QIAGEN N.V. (ETR:QIA) | Finanzwire

Basculer en Français

10294	Companies
213162	Keywords
142935	Articles
112869	Press releases

Home
Companies
QIAGEN N.V.

BRIEF

published on 04/27/2026 at 22:19, 3 hours 20 minutes ago

QIAGEN Revises 2026 Outlook Amid Mixed Q1 Results

Financial Results EPS Outlook QIAGEN Q1 2026 Sales Trends QuantiFERON
PRESS RELEASE

published on 04/27/2026 at 22:14, 3 hours 25 minutes ago

EQS-Adhoc: QIAGEN N.V.: QIAGEN announces preliminary Q1 2026 results that achieved adjusted EPS outlook with mixed sales trends; updates full-year 2026 outlook by reducing expected net sales growth and adj. EPS
QIAGEN announces preliminary Q1 2026 results meeting adjusted EPS outlook but reducing full-year net sales growth and adj. EPS. Mixed sales trends reported

Preliminary Results Full-year Outlook QIAGEN Q1 2026 Sales Trends
BRIEF

published on 11/04/2025 at 19:07, 5 months 23 days ago

QIAGEN Announces CEO Transition Plan

CEO Transition Leadership Change QIAGEN Thierry Bernard 2028 Growth Strategy
BRIEF

published on 11/04/2025 at 19:05, 5 months 23 days ago

QIAGEN Announces $500 Million Synthetic Share Repurchase

Reverse Stock Split Shareholder Approval QIAGEN N.V. Capital Repayment Synthetic Share Repurchase
PRESS RELEASE

published on 11/04/2025 at 19:02, 5 months 23 days ago

EQS-Adhoc: QIAGEN N.V.: QIAGEN announces CEO transition plan
QIAGEN N.V. announces CEO transition plan as Thierry Bernard will step down once a successor is appointed. Leadership transition initiated

CEO Transition Successor Leadership Change QIAGEN Thierry Bernard
PRESS RELEASE

published on 11/04/2025 at 19:00, 5 months 23 days ago

EQS-Adhoc: QIAGEN N.V.: QIAGEN to return approximately $500 million to shareholders through a synthetic share repurchase
QIAGEN N.V. announces $500 million shareholder return through synthetic share repurchase, enhancing EPS & reducing outstanding shares. Process details to follow

Outstanding Shares Shareholder Return QIAGEN N.V. EPS Synthetic Share Repurchase
BRIEF

published on 08/28/2025 at 08:02, 7 months 30 days ago

QIAGEN N.V. Issues Convertible Bonds Outside the US

Convertible Bonds Institutional Investors Corporate Financing QIAGEN Non-US Offering
PRESS RELEASE

published on 08/28/2025 at 07:57, 7 months 30 days ago

EQS-Adhoc: QIAGEN N.V.: QIAGEN N.V. launches non-US offering of net share settled convertible bonds
QIAGEN launches non-US offering of net share settled convertible bonds, with an aggregate volume of USD 750 million, due 2032

Convertible Bonds Offer QIAGEN Net Share Settled USD 750 Million
BRIEF

published on 05/07/2025 at 14:40, 11 months 20 days ago

QIAGEN Proposes Annual Cash Dividend to Shareholders

Investment Strategy Dividend Policy Shareholder Meeting Annual Dividend QIAGEN N.V.
PRESS RELEASE

published on 05/07/2025 at 14:35, 11 months 20 days ago

EQS-Adhoc: QIAGEN N.V.: QIAGEN to propose initiation of annual cash dividend for shareholder approval at Annual General Meeting
QIAGEN N.V. to propose initiation of annual cash dividend at Annual General Meeting, aiming to enhance shareholder returns while ensuring growth. Initial dividend payment of $0.25 per share

Annual General Meeting Shareholder Approval Dividend Policy Cash Dividend QIAGEN N.V.

Accesswire

Published on 04/28/2026 at 01:00, 39 minutes ago

Greenhawk Resources Announces Adoption of Semi-Annual Reporting
Published on 04/28/2026 at 00:40, 59 minutes ago

UraniumX Discovery Corp. Announces LOI to Enter into Option Agreement with Pond Technologies Holdings Inc. Regarding the Zoo Bay Uranium Project
Published on 04/27/2026 at 23:00, 2 hours 39 minutes ago

EQ Inc. Delivers Profitable Fourth Quarter and 28% Sequential Revenue Growth in 2025 Year End Financial Results
Published on 04/27/2026 at 17:15, 8 hours 24 minutes ago

SouthGobi Announces Discloseable Transaction Entering Into a Build-Transfer Agreement in Relation to the Dry Coal Separation System
Published on 04/27/2026 at 15:00, 10 hours 39 minutes ago

Jaguar Health Granted Extension Until May 15, 2026, to Demonstrate Compliance with Nasdaq's Bid Price Rule; Company Announces Reverse Stock Split

View all ACCESSWIRE

EQS Group

Published on 04/27/2026 at 22:14, 3 hours 25 minutes ago

EQS-Adhoc: QIAGEN N.V.: QIAGEN announces preliminary Q1 2026 results that achieved adjusted EPS outlook with mixed sales trends; updates full-year 2026 outlook by reducing expected net sales growth and adj. EPS
Published on 04/27/2026 at 21:00, 4 hours 39 minutes ago

Eleving Group announces the shareholder meeting
Published on 04/27/2026 at 19:07, 6 hours 32 minutes ago

Advancing Early Detection: OMRON Healthcare Supports May Measurement Month 2026
Published on 04/27/2026 at 18:50, 6 hours 49 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/27/2026 at 18:20, 7 hours 19 minutes ago

Convening Notice of the Company’s Extraordinary General Meeting to be held on 28 May 2026

Les Echos

Published on 04/27/2026 at 17:45, 7 hours 54 minutes ago

Convocation annual general meeting of May 27, 2026
Published on 04/27/2026 at 17:45, 7 hours 54 minutes ago

Weekly share buyback
Published on 04/27/2026 at 17:35, 8 hours 4 minutes ago

Disclosure of transactions in own shares from April 20 to April 24, 2026
Published on 04/27/2026 at 11:42, 13 hours 57 minutes ago

Description of the share repurchase program authorized by the Combined General Meeting of the shareholders of April 24, 2026
Published on 04/24/2026 at 17:45, 3 days 7 hours ago

Share buyback for cancellation

View all LES ECHOS COMFI WIRE